Halozyme Therapeutics Inc (HALO)
46.93
-0.39
(-0.82%)
USD |
NASDAQ |
Dec 20, 16:00
46.95
+0.02
(+0.04%)
After-Hours: 20:00
Halozyme Therapeutics Profit Margin (Quarterly): 47.23% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | -3.70K% |
| Novavax Inc | -143.5% |
| Kura Oncology Inc | -- |
| TransMedics Group Inc | 3.88% |
| Pulmonx Corp | -69.38% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 156.6% |
| Return on Assets | 20.54% |
| Return on Invested Capital | 22.41% |
| Gross Profit Margin (Quarterly) | 82.96% |
| Operating Margin (Quarterly) | 56.26% |
| Return on Net Operating Assets | 29.73% |